L&T report its #Q1 earnings;
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
▶️Net Profit At ₹3,617 Cr Vs CNBC-TV18 Poll Of ₹3,387 Cr
▶️Revenue At ₹63,678 Cr Vs CNBC-TV18 Poll Of ₹62,829 Cr
▶️EBITDA At ₹6,316 Cr Vs CNBC-TV18 Poll Of ₹6,362 Cr
▶️Margin At 9.9% Vs CNBC-TV18 Poll Of 10.1%
#EmcurePharma reports its #Q1 earnings:
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
👉Net Profit Up 44% At ₹207 Cr Vs ₹144 Cr (YoY)
👉Revenue Up 15.7% At ₹2,100 Cr Vs ₹1,815 Cr (YoY)
👉EBITDA Up 24% At ₹417 Cr Vs ₹336.4 Cr (YoY)
👉Margin At 20% Vs 18.5% (YoY)
Godrej Cons report #Q1Results;
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
👉Net Profit At ₹452.5 Cr Vs ₹480 Cr
👉Revenue At ₹3,662 Cr Vs ₹3,665 Cr
👉EBITDA At ₹694.8 Cr Vs ₹739 Cr
👉Margin At 19% Vs 20.2%
RITES reports #Q1results
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
Net profit up 0.7% at ₹91 cr vs ₹90.4 cr (YoY)
Revenue up 0.8% at ₹489.7 cr vs ₹485.8 cr (YoY)
EBITDA up 7.8% at ₹114 cr vs ₹106 cr (YoY)
Margin at 23.3% vs 21.8% (YoY)
💎#BayerCrop
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)
reports its #Q1 earnings:
👉Net Profit Up 9.6% At ₹278.7 Cr Vs ₹254 Cr (YoY)
👉Revenue Up 17.4% At ₹1,914.6 Cr Vs ₹1,631.4 Cr (YoY)
👉EBITDA Up 11% At ₹348.5 Cr Vs ₹314 Cr (YoY)
👉Margin At 18.2% Vs 19.3% (YoY)
❤1
The allotment of the IPO of pharmaceutical company Amanta Healthcare is going to be finalized today, September 4. This IPO received an overwhelming response from investors, and it was subscribed 82.52 times its offer size. The company had set a target of raising ₹ 126 crore through this IPO, in which 1 crore new shares were issued. Its price band was fixed at ₹ 120-126 per share. Let us tell you the step by step process to check the allotment and what is the latest GMP.